Patent · US Active

Calicheamicin derivative-carrier conjugates

US8835611B2 · kind B2 · utility

7Cited by
26References
40Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 13, 2012
Grant dateSep 16, 2014
Priority date
Expiry dateFeb 13, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for preparing monomeric cytotoxic drug/carrier conjugates with a drug loading significantly higher than in previously reported procedures and with decreased aggregation and low conjugate fraction (LCF) are described. Cytotoxic drug derivative/antibody conjugates, compositions comprising the conjugates and uses of the conjugates are also described. Monomeric calicheamicin derivative/anti-CD22 antibody conjugates, compositions comprising the conjugates and uses of the conjugates are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.